Patent classifications
C07C309/24
RADIATION-SENSITIVE RESIN COMPOSITION AND METHOD FOR FORMING RESIST PATTERN
A radiation-sensitive resin composition includes: a base resin comprising a structure unit having an acid-dissociable group; and a radiation-sensitive acid generator which comprises compounds represented by formula (2) and formula (3), and optionally a compound represented by formula (1). R.sup.1-R.sup.3 are each independently a group having a cyclic structure. X.sup.11-X.sup.32 are each independently a hydrogen atom, a fluorine atom, or a fluorinated hydrocarbon group. At least one of X.sup.11 or X.sup.12, at least one of X.sup.21 or X.sup.22, and at least one of X.sup.31 or X.sup.32 are not a hydrogen atom, respectively. A.sup.11-A.sup.32 are each independently a hydrogen atom, or a hydrocarbon group having a carbon number of 1 to 20. The radiation-sensitive resin composition does not comprise a ketone-based solvent. The the radiation-sensitive resin composition does not comprise a monovalent onium cation other than an onium cation represented by formulas (X-1), (X-3), (X-4), or (X-5).
##STR00001##
RADIATION-SENSITIVE RESIN COMPOSITION AND METHOD FOR FORMING RESIST PATTERN
A radiation-sensitive resin composition includes: a base resin comprising a structure unit having an acid-dissociable group; and a radiation-sensitive acid generator which comprises compounds represented by formula (2) and formula (3), and optionally a compound represented by formula (1). R.sup.1-R.sup.3 are each independently a group having a cyclic structure. X.sup.11-X.sup.32 are each independently a hydrogen atom, a fluorine atom, or a fluorinated hydrocarbon group. At least one of X.sup.11 or X.sup.12, at least one of X.sup.21 or X.sup.22, and at least one of X.sup.31 or X.sup.32 are not a hydrogen atom, respectively. A.sup.11-A.sup.32 are each independently a hydrogen atom, or a hydrocarbon group having a carbon number of 1 to 20. The radiation-sensitive resin composition does not comprise a ketone-based solvent. The the radiation-sensitive resin composition does not comprise a monovalent onium cation other than an onium cation represented by formulas (X-1), (X-3), (X-4), or (X-5).
##STR00001##
SYNTHESIS OF KEY INTERMEDIATE OF KRAS G12C INHIBITOR COMPOUND
The present invention relates to an improved, efficient, scalable process to prepare intermediate compounds, such as compound 5M, having the structure
##STR00001##
useful for the synthesis of compounds that target KRAS G12C mutations, such as
##STR00002##
SYNTHESIS OF KEY INTERMEDIATE OF KRAS G12C INHIBITOR COMPOUND
The present invention relates to an improved, efficient, scalable process to prepare intermediate compounds, such as compound 5M, having the structure
##STR00001##
useful for the synthesis of compounds that target KRAS G12C mutations, such as
##STR00002##
GPR40 AGONISTS
This disclosure is directed, at least in part, to GPR40 agonists useful for the treatment of conditions or disorders involving the gut-brain axis. In some embodiments, the GPR40 agonists are gut-restricted compounds. In some embodiments, the GPR40 agonists are full agonists or partial agonists. In some embodiments, the condition or disorder is a metabolic disorder, such as diabetes, obesity, nonalcoholic steatohepatitis (NASH), or a nutritional disorder such as short bowel syndrome.
GPR40 AGONISTS
This disclosure is directed, at least in part, to GPR40 agonists useful for the treatment of conditions or disorders involving the gut-brain axis. In some embodiments, the GPR40 agonists are gut-restricted compounds. In some embodiments, the GPR40 agonists are full agonists or partial agonists. In some embodiments, the condition or disorder is a metabolic disorder, such as diabetes, obesity, nonalcoholic steatohepatitis (NASH), or a nutritional disorder such as short bowel syndrome.
Synthesis of key intermediate of KRAS G12C inhibitor compound
The present invention relates to an improved, efficient, scalable process to prepare intermediate compounds, such as compound 5M, having the structure ##STR00001##
useful for the synthesis of compounds that target KRAS G12C mutations, such as ##STR00002##
Synthesis of key intermediate of KRAS G12C inhibitor compound
The present invention relates to an improved, efficient, scalable process to prepare intermediate compounds, such as compound 5M, having the structure ##STR00001##
useful for the synthesis of compounds that target KRAS G12C mutations, such as ##STR00002##
SULFUR-BASED ELECTROLYTE SOLUTION FOR MAGNESIUM CELL
An object of the present invention is to provide a highly practical electrolyte solution which has high oxidation resistance and enables dissolution-precipitation of magnesium to proceed repeatedly and stably.
The present invention relates to an electrolyte solution for a magnesium battery comprising a mixture of a compound represented by the general formula [1], a Lewis acid or a compound represented by the general formula [4], and a solvent; an electrochemical device containing the electrolyte solution; and a compound represented by the general formula [1].
##STR00001##
[In the general formula [1], X.sup.1 represents a halogeno group, and R.sup.1 represents an alkyl group having 1 to 10 carbon atoms, which may have a group represented by —SO.sub.3MgX.sup.2 (X.sup.2 represents a halogeno group); a haloalkyl group having 1 to 10 carbon atoms, which may have a group represented by —SO.sub.3MgX.sup.2 (X.sup.2 is the same as described above); an aryl group having 6 to 14 carbon atoms, which may have an alkyl group having 1 to 6 carbon atoms, an alkoxy group having 1 to 6 carbon atoms, a halogeno group, or a group represented by —SO.sub.3MgX.sup.2 (X.sup.2 is the same as described above); or a biphenyl group which may have a group represented by —SO.sub.3MgX.sup.2 (X.sup.2 is the same as described above).]
Mg[N(SO.sub.2R.sup.4).sub.2].sub.2 [4]
(In the general formula [4], four R.sup.4's each independently represent an alkyl group having 1 to 6 carbon atoms, a perfluoroalkyl group having 1 to 6 carbon atoms, a phenyl group, or a perfluorophenyl group.)
SULFUR-BASED ELECTROLYTE SOLUTION FOR MAGNESIUM CELL
An object of the present invention is to provide a highly practical electrolyte solution which has high oxidation resistance and enables dissolution-precipitation of magnesium to proceed repeatedly and stably.
The present invention relates to an electrolyte solution for a magnesium battery comprising a mixture of a compound represented by the general formula [1], a Lewis acid or a compound represented by the general formula [4], and a solvent; an electrochemical device containing the electrolyte solution; and a compound represented by the general formula [1].
##STR00001##
[In the general formula [1], X.sup.1 represents a halogeno group, and R.sup.1 represents an alkyl group having 1 to 10 carbon atoms, which may have a group represented by —SO.sub.3MgX.sup.2 (X.sup.2 represents a halogeno group); a haloalkyl group having 1 to 10 carbon atoms, which may have a group represented by —SO.sub.3MgX.sup.2 (X.sup.2 is the same as described above); an aryl group having 6 to 14 carbon atoms, which may have an alkyl group having 1 to 6 carbon atoms, an alkoxy group having 1 to 6 carbon atoms, a halogeno group, or a group represented by —SO.sub.3MgX.sup.2 (X.sup.2 is the same as described above); or a biphenyl group which may have a group represented by —SO.sub.3MgX.sup.2 (X.sup.2 is the same as described above).]
Mg[N(SO.sub.2R.sup.4).sub.2].sub.2 [4]
(In the general formula [4], four R.sup.4's each independently represent an alkyl group having 1 to 6 carbon atoms, a perfluoroalkyl group having 1 to 6 carbon atoms, a phenyl group, or a perfluorophenyl group.)